Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Golden-Shell Biochemical Co., Ltd. is a leading global manufacturer specializing in the production of chitin and chitosan derivatives. Established in 1994 and based in Yuhuan, China, the company has grown into one of the world's largest suppliers of glucosamine and chitosan for the pharmaceutical and nutraceutical sectors. Their product range includes glucosamine hydrochloride, glucosamine sulfate, and N-acetyl-D-glucosamine, which are essential components in joint health supplements. Additionally, they produce high-purity chitosan used in medical applications such as wound dressings and drug delivery systems. The company maintains rigorous quality standards, including GMP and ISO certifications, to serve a diverse international clientele. Golden Shell is recognized for its large-scale production capacity and its role as a critical raw material provider in the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Golden Shell Biochemical.